NDC 42367-540

RYANODEX dantrolene sodium

Dantrolene Sodium

RYANODEX dantrolene sodium is a Intravenous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eagle Pharmaceuticals, Inc.. The primary component is Dantrolene Sodium.

Product ID42367-540_651d74ad-433d-4ac8-a7cd-7d79460b08ac
NDC42367-540
Product TypeHuman Prescription Drug
Proprietary NameRYANODEX dantrolene sodium
Generic NameDantrolene Sodium
Dosage FormInjection, Suspension
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-07-23
Marketing CategoryNDA / NDA
Application NumberNDA205579
Labeler NameEagle Pharmaceuticals, Inc.
Substance NameDANTROLENE SODIUM
Active Ingredient Strength250 mg/5mL
Pharm ClassesDecreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42367-540-32

1 VIAL in 1 CARTON (42367-540-32) > 20 mL in 1 VIAL
Marketing Start Date2014-07-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42367-540-32 [42367054032]

RYANODEX dantrolene sodium INJECTION, SUSPENSION
Marketing CategoryNDA
Application NumberNDA205579
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-07-23

Drug Details

Active Ingredients

IngredientStrength
DANTROLENE SODIUM250 mg/5mL

OpenFDA Data

SPL SET ID:8f7b3ac0-604d-4c78-b545-5e0f8ea3d698
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1544758
  • 1544753
  • UPC Code
  • 0342367540325
  • Pharmacological Class

    • Decreased Striated Muscle Contraction [PE]
    • Decreased Striated Muscle Tone [PE]
    • Skeletal Muscle Relaxant [EPC]
    • Decreased Striated Muscle Contraction [PE]
    • Decreased Striated Muscle Tone [PE]
    • Skeletal Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "RYANODEX dantrolene sodium" or generic name "Dantrolene Sodium"

    NDCBrand NameGeneric Name
    42023-123Dantriumdantrolene sodium
    42023-124Dantriumdantrolene sodium
    42023-125Dantriumdantrolene sodium
    0115-4411Dantrolene SodiumDantrolene Sodium
    0115-4422Dantrolene SodiumDantrolene Sodium
    0115-4433Dantrolene SodiumDantrolene Sodium
    0527-3219Dantrolene Sodiumdantrolene sodium
    0527-3220Dantrolene Sodiumdantrolene sodium
    0527-3221Dantrolene Sodiumdantrolene sodium
    0904-7211Dantrolene SodiumDantrolene Sodium
    42023-144dantrolene sodiumdantrolene sodium
    49884-362dantrolene sodiumdantrolene sodium
    49884-363dantrolene sodiumdantrolene sodium
    49884-364dantrolene sodiumdantrolene sodium
    50268-217Dantrolene SodiumDantrolene Sodium
    55154-7140Dantrolene SodiumDantrolene Sodium
    63629-2168dantrolene sodiumdantrolene sodium
    63629-2169dantrolene sodiumdantrolene sodium
    63629-2170dantrolene sodiumdantrolene sodium
    64850-840Dantrolene Sodiumdantrolene sodium
    64850-841Dantrolene Sodiumdantrolene sodium
    64850-842Dantrolene Sodiumdantrolene sodium
    68084-300Dantrolene SodiumDantrolene Sodium
    27505-003Revontodantrolene sodium
    42367-540RYANODEXdantrolene sodium

    Trademark Results [RYANODEX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RYANODEX
    RYANODEX
    87328851 not registered Live/Pending
    Lytropic Therapeutics, Inc.
    2017-02-08
    RYANODEX
    RYANODEX
    87328847 not registered Live/Pending
    Lytropic Therapeutics, Inc.
    2017-02-08
    RYANODEX
    RYANODEX
    78792827 3277753 Live/Registered
    Lyotropic Therapeutics, Inc.
    2006-01-17

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.